{"id":52092,"date":"2021-03-26T00:00:00","date_gmt":"2021-03-26T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2021\/03\/26\/neurologic-symptoms-persistent-for-many-covid-19-long-haulers\/"},"modified":"2021-03-30T15:10:49","modified_gmt":"2021-03-30T15:10:49","slug":"neurologic-symptoms-persistent-for-many-covid-19-long-haulers","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2021\/03\/26\/neurologic-symptoms-persistent-for-many-covid-19-long-haulers\/","title":{"rendered":"Neurologic Symptoms Persistent for Many COVID-19 &#8216;Long-Haulers&#8217;"},"content":{"rendered":"<h3>\n<p>Main neurologic manifestations included brain fog for 81 percent and headache for 68 percent; 85 percent experience fatigue<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>FRIDAY, March 26, 2021 (HealthDay News) &#8212; For COVID-19 long-haulers, neurologic symptoms are common, with 81 percent experiencing brain fog and 85 percent with fatigue, according to a study published online March 23 in the <em>Annals of Clinical and Translational Neurology<\/em>.<\/p>\n<p>Edith L. Graham, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues conducted a prospective study of the first 100 consecutive patients (50 severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] positive and 50 negative) presenting to a Neuro-COVID-19 clinic between May and November 2020. Patients met the Infectious Diseases Society of America symptoms of COVID-19, were not hospitalized, and had neurologic symptoms lasting for more than six weeks. The frequency of neurologic symptoms was recorded, and patient-reported quality-of-life measures and standardized cognitive assessments were analyzed.<\/p>\n<p>The researchers found that depression\/anxiety and autoimmune disease were the most frequent comorbidities (42 and 16 percent, respectively). Brain fog, headache, numbness\/tingling, dysgeusia, anosmia, and myalgias were the main neurologic manifestations (81, 68, 60, 59, 55, and 55 percent, respectively); only anosmia was more frequent in SARS-CoV-2-positive versus SARS-CoV-2-negative patients (74 versus 36 percent). Fatigue was experienced by 85 percent of patients. Both groups had impaired quality of life in the cognitive and fatigue domains. Compared with a demographic-matched U.S. population, SARS-CoV-2-positive patients performed worse in attention and working-memory cognitive tasks.<\/p>\n<p>&#8220;The long-term impact of &#8216;long COVID&#8217; on quality of life and potential return to normalcy, through lost productivity and lingering cognitive dysfunction, may be substantial as the pandemic continues to escalate,&#8221; the authors write.<\/p>\n<p><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/acn3.51350\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2021 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Main neurologic manifestations included brain fog for 81 percent and headache for 68 percent; 85 percent experience fatigue<\/p>\n","protected":false},"author":6,"featured_media":52289,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-52092","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/52092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=52092"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/52092\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/52289"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=52092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=52092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=52092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}